slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,651-28,680
Pages 10,126
Rows per page 30
Component
28,651-28,680 of 303,780
172
Uses a direct quote from a KOL to undermine the company's growth thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
173
Uses expert testimonials to debunk company growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
174
Features highlighted text blocks in yellow to emphasize critical quotes from former executives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
175
Uses expert testimony to frame the company's situation as dire.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
183
Uses expert testimony to debunk market optimism regarding M&A.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
184
The slide uses expert testimony to debunk the bull case of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
185
The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
192
Includes a direct testimonial quote highlighted in yellow.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
193
Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
196
Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
197
The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
199
The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
200
Uses highlighted text to emphasize key negative sentiment from KOLs.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
201
Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
202
Uses direct quotes from high-volume implanters to contradict the market growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
203
The slide uses a series of testimonials to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
204
The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
205
The slide uses expert testimony to debunk the company's growth claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
206
Includes a direct testimonial from a high-volume implanter to support the thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
207
The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits
208
Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 2 hits